NO20005570L - Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalåpnere - Google Patents

Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalåpnere

Info

Publication number
NO20005570L
NO20005570L NO20005570A NO20005570A NO20005570L NO 20005570 L NO20005570 L NO 20005570L NO 20005570 A NO20005570 A NO 20005570A NO 20005570 A NO20005570 A NO 20005570A NO 20005570 L NO20005570 L NO 20005570L
Authority
NO
Norway
Prior art keywords
cyclopentanone
compounds useful
potassium channel
channel openers
dihydropyridine compounds
Prior art date
Application number
NO20005570A
Other languages
English (en)
Other versions
NO20005570D0 (no
Inventor
William A Carroll
Yiyuan Chen
Irene Drizin
James F Kerwin
Jimmie L Moore
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20005570L publication Critical patent/NO20005570L/no
Publication of NO20005570D0 publication Critical patent/NO20005570D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20005570A 1999-03-04 2000-11-03 Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalÕpnere NO20005570D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/262,441 US6518279B2 (en) 1999-03-04 1999-03-04 Cyclopentanone dihydropyridine compounds useful as potassium channel openers
PCT/US2000/005828 WO2000051986A1 (en) 1999-03-04 2000-03-06 Cyclopentanone dihydropyridine compounds useful as potassium channel openers

Publications (2)

Publication Number Publication Date
NO20005570L true NO20005570L (no) 2000-11-03
NO20005570D0 NO20005570D0 (no) 2000-11-03

Family

ID=22997528

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005570A NO20005570D0 (no) 1999-03-04 2000-11-03 Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalÕpnere

Country Status (20)

Country Link
US (1) US6518279B2 (no)
EP (1) EP1075466A1 (no)
JP (1) JP2003517454A (no)
KR (1) KR20010043295A (no)
CN (1) CN1318053A (no)
AR (1) AR028987A1 (no)
AU (1) AU3616800A (no)
BG (1) BG104999A (no)
BR (1) BR0005189A (no)
CA (1) CA2330541A1 (no)
CO (1) CO5150208A1 (no)
HU (1) HUP0102895A3 (no)
IL (1) IL139140A0 (no)
MX (1) MXPA00010790A (no)
NO (1) NO20005570D0 (no)
PL (1) PL343883A1 (no)
SK (1) SK18152000A3 (no)
TR (1) TR200003202T1 (no)
WO (1) WO2000051986A1 (no)
ZA (1) ZA200005798B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593335B1 (en) 1997-12-18 2003-07-15 Abbott Laboratories Potassium channel openers
US6265417B1 (en) 1997-12-18 2001-07-24 Abbott Laboratories Potassium channel openers
DE60131660D1 (de) * 2000-08-02 2008-01-10 Astrazeneca Ab Verfahren zur asymetrischen synthese von substituierten 1,4-dihydropyridin-derivaten
US20030045449A1 (en) * 2001-08-15 2003-03-06 Pfizer, Inc. Pharmaceutical combinations for the treatment of neurodegenerative diseases
US20030199578A1 (en) * 2002-04-19 2003-10-23 Turner Sean C. Naphthalene amides as potassium channel openers
WO2007095424A1 (en) * 2006-02-10 2007-08-23 Janssen Pharmaceutica N.V. Novel tricyclic dihydropyrazines as potassium channel openers
EP2398790B1 (en) 2009-02-18 2013-07-03 Bayer Intellectual Property GmbH Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
WO2021253180A1 (en) * 2020-06-15 2021-12-23 Novartis Ag Methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-4, 5, 6, 7-tetrahydro-1h-cyclopenta [b] pyridine-3-carboxylate and methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-1, 4, 5, 7-tetrahydrofuro [3, 4-b] pyridine-3-carboxylate as cav1.2 activators
US11939316B1 (en) 2023-11-06 2024-03-26 King Faisal University 9-(6-flouro-2-hydroxyouinolin-3-yl)-10-(2-hydroxyethyl)-3,6-diphenyl-3,4,6,7,9,10-hexhydroacridine-1,8(2h,5h)-dione as an antimicrobial compound
US11970478B1 (en) 2023-11-16 2024-04-30 King Faisal University 9-(2-hydroxyquinolin-3-yl)-10-(2-hydroxyethyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2003148A1 (de) 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
DE3447170A1 (de) 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Mischung unterschiedlicher dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
GB8716971D0 (en) 1987-07-17 1987-08-26 Pfizer Ltd Therapeutic agents
GB8907401D0 (en) 1989-04-01 1989-05-17 Pfizer Ltd Therapeutic agents
JP3285963B2 (ja) 1991-10-21 2002-05-27 インペリアル・ケミカル・インダストリーズ・ピーエルシー 治療剤
GB9220570D0 (en) 1991-10-21 1992-11-11 Ici Plc Therapeutic agent
GB9318935D0 (en) 1992-10-20 1993-10-27 Zeneca Ltd Heterocyclic derivatives
DE4313690A1 (de) 1993-04-27 1994-11-03 Bayer Ag Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE69823227T2 (de) 1997-12-18 2005-03-10 Abbott Laboratories, Abbott Park Kaliumkanalöffner

Also Published As

Publication number Publication date
TR200003202T1 (tr) 2001-08-21
ZA200005798B (en) 2002-01-18
BR0005189A (pt) 2001-01-09
HUP0102895A3 (en) 2002-01-28
SK18152000A3 (sk) 2001-06-11
MXPA00010790A (es) 2002-06-04
HUP0102895A2 (hu) 2001-12-28
CA2330541A1 (en) 2000-09-08
NO20005570D0 (no) 2000-11-03
CO5150208A1 (es) 2002-04-29
AR028987A1 (es) 2003-06-04
JP2003517454A (ja) 2003-05-27
US6518279B2 (en) 2003-02-11
EP1075466A1 (en) 2001-02-14
WO2000051986A1 (en) 2000-09-08
PL343883A1 (en) 2001-09-10
BG104999A (en) 2001-10-31
IL139140A0 (en) 2001-11-25
CN1318053A (zh) 2001-10-17
AU3616800A (en) 2000-09-21
US20020007065A1 (en) 2002-01-17
KR20010043295A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
NO20012739D0 (no) 3-substituerte-4-arylquinolin-2-on-derivater som kaliumkanal modulatorer
NO20003930L (no) Sammensetninger som inneholder organiske forbindelser
NO20033683L (no) 2,4-disubstituerte pyrimidin-5-karboksamidderivater som KCNQ kaliumkanal modulatorer
NO20014412D0 (no) Forbindelser nyttige som anti-inflammatoriske midler
NO20031001D0 (no) Polyarylkarboksamider nyttige som lipidsenkende midler
GB2390091B (en) Bisarylamines as potassium channel openers
DK1451192T3 (da) Ny krystallinsk forbindelse
DK1326858T3 (da) Piperidinforbindelser som anti-allergiske midler
AU5557700A (en) New uses for potassium channel openers
AU2003215172A1 (en) Message accessing
DK1522539T3 (da) Krystallinsk komposition indeholdende excitalopram
NO20022649D0 (no) Heterocykliske dihydropyrimidiner som kaliumkanal inhibitorer
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
DK1086097T3 (da) Sulfonylbenzenforbindelser som anti-inflammatoriske/analgetiske midler
PL373583A1 (en) Novel piperidine compound
NO20005570L (no) Cyklopentanondihydropyridinforbindelser anvendbare som kaliumkanalåpnere
NO20013860L (no) 16-hydroksyöstratriener som selektive östrogener
DE60331767D1 (de) beta-1,4-MANNOBIOSE ENTHALTENDE ZUSAMMENSETZUNG
DK1075471T3 (da) Idolylderivater som serotonerge midler
WO2002010164A3 (en) Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
AU2003205961A1 (en) Photo-sensitive composition
AUPQ933200A0 (en) Pulley for double hung windows
AU2003223899A1 (en) Seal for spindles
HK1037873A (en) Cyclopentanone dihydropyridine compounds useful as potassium channel openers
AU2003258562A1 (en) Thermally labile bleaching composition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application